These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 22027306)

  • 1. Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump.
    Agrawal P; Welsh JB; Kannard B; Askari S; Yang Q; Kaufman FR
    J Diabetes Sci Technol; 2011 Sep; 5(5):1137-41. PubMed ID: 22027306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk.
    Choudhary P; Shin J; Wang Y; Evans ML; Hammond PJ; Kerr D; Shaw JA; Pickup JC; Amiel SA
    Diabetes Care; 2011 Sep; 34(9):2023-5. PubMed ID: 21868778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Methods to Understand the Temporal Nature and Accuracy of Delivery for Insulin Infusion Pumps.
    Kumar SS; Karia D; Gopkumar A; Koty PG; Arora M
    J Diabetes Sci Technol; 2024 May; 18(3):618-624. PubMed ID: 35929433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory theory of diseases: What has it got to do with late-onset LGS?
    Singh A
    Neurol Clin Pract; 2018 Oct; 8(5):375-376. PubMed ID: 30564489
    [No Abstract]   [Full Text] [Related]  

  • 5. A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes.
    Ly TT; Brnabic AJ; Eggleston A; Kolivos A; McBride ME; Schrover R; Jones TW
    Value Health; 2014 Jul; 17(5):561-9. PubMed ID: 25128049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
    Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW
    JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Evolution of Insulin Administration in Type 1 Diabetes.
    Pinnaro CT; Tansey MJ
    J Diabetes Mellitus; 2021 Nov; 11(5):249-277. PubMed ID: 37745178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Closed-Loop Insulin Delivery Systems: Past, Present, and Future Directions.
    Templer S
    Front Endocrinol (Lausanne); 2022; 13():919942. PubMed ID: 35733769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Where Do We Stand with Closed-Loop Systems and Their Challenges?
    Jackson M; Castle JR
    Diabetes Technol Ther; 2020 Jul; 22(7):485-491. PubMed ID: 32069100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications.
    Cappon G; Vettoretti M; Sparacino G; Facchinetti A
    Diabetes Metab J; 2019 Aug; 43(4):383-397. PubMed ID: 31441246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining continuous glucose monitoring and insulin pumps to automatically tune the basal insulin infusion in diabetes therapy: a review.
    Vettoretti M; Facchinetti A
    Biomed Eng Online; 2019 Mar; 18(1):37. PubMed ID: 30922295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.
    Bekiari E; Kitsios K; Thabit H; Tauschmann M; Athanasiadou E; Karagiannis T; Haidich AB; Hovorka R; Tsapas A
    BMJ; 2018 Apr; 361():k1310. PubMed ID: 29669716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivariable Adaptive Artificial Pancreas System in Type 1 Diabetes.
    Cinar A
    Curr Diab Rep; 2017 Aug; 17(10):88. PubMed ID: 28812204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes.
    Steineck I; Ranjan A; Nørgaard K; Schmidt S
    J Diabetes Sci Technol; 2017 Jan; 11(1):50-58. PubMed ID: 28264173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Automated Insulin Management Features of the MiniMed
    Zhong A; Choudhary P; McMahon C; Agrawal P; Welsh JB; Cordero TL; Kaufman FR
    Diabetes Technol Ther; 2016 Oct; 18(10):657-663. PubMed ID: 27672710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemia Detection and Carbohydrate Suggestion in an Artificial Pancreas.
    Turksoy K; Kilkus J; Hajizadeh I; Samadi S; Feng J; Sevil M; Lazaro C; Frantz N; Littlejohn E; Cinar A
    J Diabetes Sci Technol; 2016 Nov; 10(6):1236-1244. PubMed ID: 27464755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study.
    Weiss R; Garg SK; Bode BW; Bailey TS; Ahmann AJ; Schultz KA; Welsh JB; Shin JJ
    Diabetes Technol Ther; 2015 Aug; 17(8):542-7. PubMed ID: 26237308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Hypoglycemia in the ASPIRE In-Home Study and Effects of Automatic Suspension of Insulin Delivery.
    Weiss R; Garg SK; Bergenstal RM; Klonoff DC; Bode BW; Bailey TS; Thrasher J; Schwartz F; Welsh JB; Kaufman FR;
    J Diabetes Sci Technol; 2015 May; 9(5):1016-20. PubMed ID: 25986629
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.